	The Synergistic Role of Phenolic Compounds in Docetaxel Chemoresistance in Prostate Cancer: A Systematic Review and Meta-Analysis. Curr Pharm Des Tatiparthi R, Aljabali AAA, Mishra Y, Mishra V. PMID: 42634543 [PubMed - as supplied by publisher]
	Editorial Comment on Exploratory Time-Dependent Patterns in Estimated Treatment Effect of Talazoparib Plus Enzalutamide in HRR Non-Deficient or Unknown Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the TALAPRO-2 Trial. Int J Urol Utsumi T. PMID: 42634253 [PubMed - in process]
	Diet and risk of bladder cancer: a systematic review of epidemiological evidence. BJU Int Miyajima K, Miszczyk M, Roessler N, Inoue S, Rajwa P, Matsukawa A, Urabe F, Mori K, Yanagisawa T, Karakiewicz PI, Teoh JY, Briganti A, Yang L, Schernhammer E, Kimura T, Shariat SF. PMID: 42634248 [PubMed - as supplied by publisher]
	Skin Rash Management Based on Early Elevation in the Eosinophil Proportion Within 3â€‰Months of Initiating Apalutamide for Prostate Cancer. Cancer Rep (Hoboken) Koguchi D, Tsumura H, Tabata KI, Satoh T, Tachibana T, Hirano S, Ikeda M, Ishii D, Matsumoto K. PMID: 42634213 [PubMed - indexed for MEDLINE]
	Early patient-reported outcomes and decisional regret after robot-assisted radical prostatectomy: A prospective single-center cohort study. J Robot Surg Roh Y, Shin D, Park YH, Cho HJ, Ha US, Hong SH, Lee JY, Bang S. PMID: 42634057 [PubMed - indexed for MEDLINE]
	Single-port versus multi-port robot-assisted partial nephrectomy for predominantly low-complexity renal tumors: a systematic review and meta-analysis. J Robot Surg Liu W, Su J. PMID: 42634038 [PubMed - indexed for MEDLINE]
	Stereotactic Prostate Cancer Ablative Re-Irradiation: A Systematic Review and Meta-Analysis (SPARE). Prostate Gouveia AG, Tao J, Pond G, Dong K, Ye A, Rosa AA, Palhares DM, Villafuerte CJQ, Anselmo P, Moraes FY, Arcidiacono F, Olson R, Tsakiridis T. PMID: 42633701 [PubMed - as supplied by publisher]
	circ-ITCH suppresses prostate cancer cell proliferation, migration and invasion in-vitro through the miR-106b-5p/SETD2 axis. Pak J Pharm Sci Jiang J, Wei J, Chen F, Li Y, Ba L, Pan B. PMID: 42633546 [PubMed - indexed for MEDLINE]
	Real-World Comparison of Abiraterone Acetate Versus Docetaxel in Combination With Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Cohort Study From Vietnam. Cancer Control Nguyen H, Nguyen H, Nguyen HX, Truong M, Ngo T. PMID: 42633534 [PubMed - indexed for MEDLINE]
	Mitochondrial convergence of ferroptosis and cuproptosis in castration-resistant prostate cancer: From metabolic vulnerabilities to therapeutic targeting. BBA Adv Wang CL, Lv JT, Liu SJ, Zhang YY, Wang SL, Song SQ. PMID: 42633322 [PubMed]
	Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis. Urol Oncol Teixeira EG, Torres LAF, Defante MLR, de Azevedo FM, Souza VC. PMID: 42632294 [PubMed - as supplied by publisher]
	A phase-specific benefit-toxicity framework for perioperative trials in muscle-invasive bladder cancer: A focused review andtrial-level mapping analysis. Urol Oncol Shinohara M, Narita T, Hamaya T, Ichiyama T, Fujita N, Okamoto T, Yamamoto H, Ohyama C, Hatakeyama S. PMID: 42632293 [PubMed - as supplied by publisher]
	miR-638 Upregulation in Serum and Tissues Functions as a Diagnostic and Prognostic Biomarker and Facilitates Prostate Cancer Progression. Urol Oncol Wang L, Yang H, Wang J. PMID: 42632292 [PubMed - as supplied by publisher]
	Clinical characteristics, treatment patterns, and survival outcomes in ductal prostate cancer: a multicenter retrospective analysis. World J Urol Handke A, Paffenholz P, Schlack K, Seifert KE, Linxweiler J, Mink J, Flockerzi F, Nestler T, Wenzel M, Siech C, Darr C, Grünwald V, Roghmann F, Tully KH. PMID: 42631874 [PubMed - indexed for MEDLINE]
	The Intersection of Religiosity, Perceived Discrimination, and Psychological Well-Being in a Racially and Ethnically Diverse Sample of Male Cancer Survivors. Cancer Control Murphy A, Fletcher-Duncan A, Cherell CD, Li X, Fan W, Jacobs KL, Denis J, Lezama C, Bethune B, Hu B, Gonzalez BD, Green BL. PMID: 42631521 [PubMed - indexed for MEDLINE]
	Optimizing Sequential Decision Rules for Prostate Cancer Biopsy Management: A Multi-Objective Statistical Framework. J Am Stat Assoc Qiu J, Zhao YQ, Wei J, Chinnaiyan AM, Tosoian J, Zheng Y. PMID: 42631260 [PubMed]
	Mitochondrial Dysfunction in Renal Cell Carcinoma: A Comprehensive Review of Pathogenic Mechanisms and Emerging Therapeutic Opportunities. Oncol Res Wang Y, Liu J, Xu Q, Ma Z. PMID: 42630702 [PubMed - indexed for MEDLINE]
	Combining PSA density and imaging data with transcript markers from urinary cells to improve prediction of prostate cancer reclassification in patients on active surveillance. BJUI Compass Borkowetz A, Gräfe S, Kwe J, Fuessel S, Thomas C, Erdmann K. PMID: 42630620 [PubMed]
	Patterns of first-line treatment selection in metastatic renal cell carcinoma: a real-world analysis from the Meet-URO 33-REGAL study. Ther Adv Med Oncol Bimbatti D, Nasso C, Aspden D, Buti S, Antonj L, Signori A, Verzoni E, Lolli C, Di Napoli M, Fanelli M, De Lucia M, Masini C, Roviello G, Arduini D, Filippi R, Mennitto A, Sorarù M, Bozza G, Formisano L, Messina C, Bonomi L, Guida A, Fantinel E, Scagliarini S, Vitale MG, Chiellino S, Maiorano BA, Deppieri FM, Zucali PA, Cavo A, Caserta C, La Russa F, Conteduca V, Maines F, Zai S, Pierantoni F, Icardi M, Rescigno P, Di Costanzo F, Banna GL, Rebuzzi SE. PMID: 42630506 [PubMed]
	Efficacy of neoadjuvant novel hormonal therapy combined with radical prostatectomy for high-risk prostate cancer and analysis of biochemical recurrence-free survival. Am J Transl Res Jiang S, Du C, Qu L, Liu L, Ren B, Luo W. PMID: 42630365 [PubMed]

Articles 1 - 20 / 180915

Page 1 of 9046



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy